What’s Going On With Boeing Shares Today?
Boeing shares decline as FAA admits to insufficient oversight, while the company faces a new quality issue with its 787 Dreamliner.
NextDecade Locks In 20-Year LNG Supply Deal With Aramco: Details
NextDecade and Aramco signed non-binding HoA for 1.2MTPA LNG deal from Train 4 in Texas. Aramco plans to buy for 20 years with pricing indexed to Henry Hub.
Why Consulting Firm Korn Ferry Shares Are Surging Today
Korn Ferry reports Q4 FY24 results, with revenue beating expectations and increased dividend. Stock up over 6%.
Big Oil Battles Biden: Chevron, Exxon Challenge EV Emission Rules
Oil giants Chevron & Exxon Mobil plan to sue Biden admin over push for electric vehicles. Lawsuit aims to block EPA's emission rules.
ChargePoint Inks Pact With Porsche Cars North America – What’s Going On?
ChargePoint partners with Porsche Cars North America, expanding charging options for Porsche drivers across North America.
Google Heats Up Green Goals: Geothermal Deal Powers Nevada Data Centers
Google partners with NV Energy to supply Nevada data centers with carbon-free geothermal electricity, moving closer to its clean energy goal by 2030.
What’s Going On With Home Furnishing Brand Lovesac Shares After Q1 Earnings?
Lovesac (NASDAQ: LOVE) shares rise after reporting Q1 results, with narrower-than-expected loss and strong sales performance.
What’s Going On With Innovative Eyewear Shares Today?
Innovative Eyewear introduces LUCY Bixby app for hands-free ChatGPT access on its glasses, enhancing utility for Samsung users.
Sony Steps Into Theater Business With Alamo Drafthouse Purchase
Sony Pictures Entertainment, part of Sony Group Corp, has acquired the Alamo Drafthouse Cinema, renowned for its unique dine-in movie experience. This move aims to rejuvenate the theater industry, especially as major cities like New York and Los Angeles see a dip in box-office performance.
Regeneron’s Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market
Analyst projects Regeneron's Dupixent to drive COPD sales surge, envisioning $20B market by 2026 on larger addressable market.